1
Nov
2022

Jeil Pharmaceutical Co., Ltd.

Exhibitor at CPHI Frankfurt 2022 stand 61B76, Finished Dosage Formulations
About Us

Jeil Pharmaceutical Co., Ltd. founded in 1959 has developed and supplied superior pharmaceutical products to promote the happiness and health of mankind and has contributed to the growth and development of the pharmaceutical industry in Korea. Jeil’s factory received KGMP approval in 1987, and produces tablets, capsules, injections, finished pharmaceutical products including patches, and Active Pharmaceutical Ingredients(APIs) such as anti-biotic ingredients, etc. 

  • KR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
API Producer
Cosmeceuticals
Generic APIs producer
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 61B76, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2022